Home
HelpTest Code FCZAC Certolizumab and Anti-Certolizumab Antibody, DoseASSURE CTZ
Specimen Required
Patient Preparation: High serum biotin concentrations in patients taking biotin supplements may cause an interference in this assay. Patients may be advised to stop biotin consumption at least 72 hours prior to sample collection.
Collection Container/Tube:
Preferred: Red top
Acceptable: Serum gel
Submission Container/Tube: Plastic vial
Specimen Volume: 2 mL Serum
Collection Instructions:
1. Allow a minimum clotting time of 30 to 60 minutes.
2. Within 2 hours of collection, centrifuge and aliquot serum into a plastic vial.
3. Send frozen.
To avoid delays in turnaround time when requesting multiple tests, submit separate frozen specimens for each test requested.
Reporting Name
Certolizumab and Anti-Certo AbSpecimen Type
SerumSpecimen Minimum Volume
Serum: 0.6 mL, Note: This volume does not allow for repeat testing.
Specimen Stability Information
| Specimen Type | Temperature | Time |
|---|---|---|
| Serum | Frozen (preferred) | 14 days |
| Refrigerated | 14 days |
Reject Due To
| Gross hemolysis | Reject |
| Gross lipemia | Reject |
| Incorrect specimen type | Reject |
Reference Values
Certolizumab:
Quantitation Limit: <1.0 ug/mL
Results of 1 ug/mL or higher indicate detection of certolizumab
Anti-Certolizumab Antibody:
Quantitation Limit: <40 ng/mL
Results of 40 ng/mL or higher indicate detection of anti-certolizumab pegol antibodies.
Performing Laboratory
Esoterix EndocrinologyCPT Code Information
80299
82397
LOINC Code Information
| Test ID | Test Order Name | Order LOINC Value |
|---|---|---|
| FCZAC | Certolizumab and Anti-Certo Ab | Not Provided |
| Result ID | Test Result Name | Result LOINC Value |
|---|---|---|
| Z5637 | Certolizumab | 87404-0 |
| Z5638 | Anti-Certolizumab Antibody | 87405-7 |
Day(s) Performed
Tuesday